Which screening method is typically targeted toward individuals who show symptoms or have risk factors rather than the general population?

Prepare for the PNLE Nursing Practice I Test with targeted quizzes. Tackle multiple-choice questions designed to assess your nursing knowledge and skills. Equip yourself with the expertise needed to excel in your exam!

Multiple Choice

Which screening method is typically targeted toward individuals who show symptoms or have risk factors rather than the general population?

Explanation:
The idea being tested is targeting screening to people who show symptoms or have risk factors rather than screening everyone. This approach, case finding, focuses on individuals who present with signs, symptoms, or known exposures and prompts diagnostic testing based on those factors. It’s efficient and practical because it concentrates resources where the likelihood of disease is higher, enabling timely detection without testing the entire population. In contrast, mass screening tests everyone regardless of symptoms or risk, which can be resource-intensive. Multiphasic screening uses multiple tests on a broad group, not specifically guided by individual risk. Surveillance involves collecting and analyzing data on disease occurrence over time, rather than actively screening individuals.

The idea being tested is targeting screening to people who show symptoms or have risk factors rather than screening everyone. This approach, case finding, focuses on individuals who present with signs, symptoms, or known exposures and prompts diagnostic testing based on those factors. It’s efficient and practical because it concentrates resources where the likelihood of disease is higher, enabling timely detection without testing the entire population.

In contrast, mass screening tests everyone regardless of symptoms or risk, which can be resource-intensive. Multiphasic screening uses multiple tests on a broad group, not specifically guided by individual risk. Surveillance involves collecting and analyzing data on disease occurrence over time, rather than actively screening individuals.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy